Form 4 for CI Cigna
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001739940-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-02-27 | CI | Evanko Brian C | See Remarks | A - Grant | $0.00 | +16.2K | 32.9K | +97% | $0 |
| DM | 2026-03-03 | 2026-02-27 | CI | Evanko Brian C | See Remarks | F - Tax | $287.55 | -4,767 | 39.7K | -11% | -$1.37M |
| D | 2026-03-03 | 2026-02-27 | CI | Evanko Brian C | See Remarks | A - Grant | $0.00 | +15.1K | 15.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2026-02-27 | A | A | 9,787 | $0.00 | 42,684 | D | — | — | (F2) These restricted shares vest in three equal annual installments beginning March 1, 2027. |
| 2 | Common | Common Stock, $.01 Par Value | 2026-02-27 | A | A | 6,428 | $0.00 | 32,897 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| 3 | Common | Common Stock, $.01 Par Value | 2026-02-27 | F | D | 1,788 | $287.55 | 37,917 | D | — | — | (F4) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| 4 | Common | Common Stock, $.01 Par Value | 2026-02-27 | F | D | 2,979 | $287.55 | 39,705 | D | — | — | (F3) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-27 | A | A | 15,082 | $0.00 | 15,082 | D | $287.55 · 2027-03-01 to 2036-02-27 | 15,082 Common Stock, $.01 Par Value | (F7) This option vests in three equal annual installments beginning March 1, 2027. |